These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 6411445)

  • 21. Antiarrhythmic actions of tocainide in canine models of previous myocardial infarction.
    Wallace AA; Stupienski RF; Heaney LA; Gehret JR; Lynch JJ
    Am Heart J; 1991 May; 121(5):1413-21. PubMed ID: 1708198
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mexiletine and tocainide: orally active congeners of lidocaine.
    Wulf BG
    Clin Pharm; 1983; 2(4):340-6. PubMed ID: 6411416
    [No Abstract]   [Full Text] [Related]  

  • 23. Ventricular arrhythmias: current concepts.
    Nestico PF; Morganroth J
    Compr Ther; 1984 Sep; 10(9):32-6. PubMed ID: 6435947
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of tocainide enantiomers on experimental arrhythmias produced by programmed electrical stimulation.
    Uprichard AC; Allen JD; Harron DW
    J Cardiovasc Pharmacol; 1988 Feb; 11(2):235-41. PubMed ID: 2452320
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical profiles of newer class I antiarrhythmic agents--tocainide, mexiletine, encainide, flecainide and lorcainide.
    Pottage A
    Am J Cardiol; 1983 Sep; 52(6):24C-31C. PubMed ID: 6414279
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Randomized double-blind study of intravenous tocainide versus lidocaine for suppression of ventricular arrhythmias after cardiac surgery.
    Manolis AS; Smith E; Payne D; Rastegar H; Cleveland R; Estes NA
    Clin Cardiol; 1990 Mar; 13(3):177-81. PubMed ID: 2108835
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Therapy with conventional antiarrhythmic drugs for ventricular arrhythmias.
    Nestico PF; DePace NL; Morganroth J
    Med Clin North Am; 1984 Sep; 68(5):1295-319. PubMed ID: 6436595
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinical pharmacology of anti-arrhythymia agents. II. Lignocaine, mexiletine, tocainide, phenytoin].
    Witkowska M
    Kardiol Pol; 1981; 24(11-12):803-13. PubMed ID: 6804681
    [No Abstract]   [Full Text] [Related]  

  • 29. Efficacy and safety of intravenous tocainide compared with intravenous lidocaine for acute ventricular arrhythmias immediately after cardiac surgery.
    Morganroth J; Panidis IP; Harley S; Johnson J; Smith E; MacVaugh H
    Am J Cardiol; 1984 Dec; 54(10):1253-8. PubMed ID: 6439023
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Class IB antiarrhythmic drugs: tocainide, mexiletine, and moricizine.
    Snyder DW
    J La State Med Soc; 1989 May; 141(5):21-5. PubMed ID: 2499645
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chronic tocainide therapy for refractory high-grade ventricular arrhythmias.
    Haffajee CI; Sacks GM; Alpert JS; Howe JP; Ockene IS; Paraskos JA; Dalen JE
    Clin Cardiol; 1983 Feb; 6(2):72-8. PubMed ID: 6403267
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term tocainide therapy for ventricular arrhythmias.
    Winkle RA; Meffin PJ; Harrison DC
    Circulation; 1978 May; 57(5):1008-16. PubMed ID: 639200
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical pharmacokinetics of the newer antiarrhythmic agents.
    Gillis AM; Kates RE
    Clin Pharmacokinet; 1984; 9(5):375-403. PubMed ID: 6437721
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy and safety of oral tocainide in refractory ventricular arrhythmia: a preliminary report on an open label study.
    Mahapatra RK; Mahapatra D
    Angiology; 1986 Apr; 37(4):285-93. PubMed ID: 2424347
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Canine digitalis arrhythmia as a model for detecting Na-channel blocking antiarrhythmic drugs: a comparative study using other canine arrhythmia models and the new antiarrhythmic drugs, propafenone, tocainide, and SUN 1165.
    Hashimoto K; Ishii M; Komori S; Mitsuhashi H
    Heart Vessels; 1985 Feb; 1(1):29-35. PubMed ID: 2419304
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mexiletine and tocainide: a comparison of antiarrhythmic efficacy, adverse effects, and predictive value of lidocaine testing.
    Murray KT; Barbey JT; Kopelman HA; Siddoway LA; Echt DS; Woosley RL; Roden DM
    Clin Pharmacol Ther; 1989 May; 45(5):553-61. PubMed ID: 2498025
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tocainide in the cardiac ICU.
    Benning CA; Burke PA
    Crit Care Nurse; 1989 Feb; 9(2):45-53. PubMed ID: 2510974
    [No Abstract]   [Full Text] [Related]  

  • 38. Tocainide for drug-resistant sustained ventricular tachyarrhythmias.
    Adhar GC; Swerdlow CD; Lance BL; Clay D; Bardy GH; Greene HL
    J Am Coll Cardiol; 1988 Jan; 11(1):124-31. PubMed ID: 3121711
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tocainide plus quinidine for treatment of ventricular arrhythmias.
    Barbey JT; Thompson KA; Echt DS; Woosley RL; Roden DM
    Am J Cardiol; 1988 Mar; 61(8):570-3. PubMed ID: 3125737
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New antiarrhythmic drugs.
    Nestico PF; Morganroth J; Horowitz LN
    Drugs; 1988 Mar; 35(3):286-319. PubMed ID: 3286214
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.